| A UMLS-based spell checker for natural language processing in vaccine safety HD Tolentino, MD Matters, W Walop, B Law, W Tong, F Liu, P Fontelo, ... BMC medical informatics and decision making 7, 1-13, 2007 | 59 | 2007 |
| The cost implications of off-pump versus on-pump coronary artery bypass graft surgery at one year A Lamy, W Tong, PJ Devereaux, P Gao, A Gafni, K Singh, D Taggart, ... The Annals of Thoracic Surgery 98 (5), 1620-1625, 2014 | 31 | 2014 |
| Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to … A Bagai, WJ Cantor, M Tan, W Tong, A Lamy, D Fitchett, EA Cohen, ... American heart journal 165 (4), 630-637. e2, 2013 | 31 | 2013 |
| The cost implications of an early versus delayed invasive strategy in acute coronary syndromes: the TIMACS study KR Bainey, A Gafni, P Rao-Melacini, W Tong, PG Steg, DP Faxon, A Lamy, ... Journal of Medical Economics 17 (6), 415-422, 2014 | 13 | 2014 |
| The cost implication of primary prevention in the HOPE 3 trial A Lamy, E Lonn, W Tong, B Swaminathan, H Jung, A Gafni, J Bosch, ... European Heart Journal-Quality of Care and Clinical Outcomes 5 (3), 266-271, 2019 | 12 | 2019 |
| Cost implications of the use of basal insulin glargine in people with early dysglycemia: the ORIGIN trial A Lamy, W Tong, H Jung, A Gafni, K Singh, J Tyrwhitt, S Yusuf, ... Journal of Diabetes and its Complications 28 (4), 553-558, 2014 | 12 | 2014 |
| The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial A Lamy, W Tong, P Gao, S Chrolavicius, A Gafni, S Yusuf, SJ Connolly Canadian Journal of Cardiology, 2011 | 12 | 2011 |
| Cost implication of an early invasive strategy on weekdays and weekends in patients with acute coronary syndromes A Lamy, WR Tong, K Bainey, A Gafni, P Rao-Melacini, SR Mehta Canadian Journal of Cardiology 31 (3), 314-319, 2015 | 10 | 2015 |
| Concept negation in free text components of vaccine safety reports H Tolentino, M Matters, W Walop, B Law, W Tong, F Liu, P Fontelo, K Kohl, ... AMIA Annual Symposium Proceedings 2006, 1122, 2006 | 10 | 2006 |
| The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study A Lamy, X Wang, P Gao, W Tong, A Gafni, A Dans, A Avezum, R Ferreira, ... Journal of Medical Economics 14 (6), 792-797, 2011 | 9 | 2011 |
| The cost-effectiveness of Rivaroxaban with or without aspirin in the COMPASS trial A Lamy, J Eikelboom, W Tong, F Yuan, SI Bangdiwala, J Bosch, ... European Heart Journal-Quality of Care and Clinical Outcomes 9 (5), 502-510, 2023 | 7 | 2023 |
| The cost implications of a polypill for primary prevention in the TIPS-3 trial A Lamy, W Tong, P Joseph, P Gao, P Pais, P Lopez-Jaramillo, ... European Heart Journal-Quality of Care and Clinical Outcomes 8 (8), 899-908, 2022 | 7 | 2022 |
| Costs impact rivaroxaban plus aspirin versus aspirin in the COMPASS trial A Lamy, J Eikelboom, S Connolly, J Bosch, KA Fox, W Tong, F Yuan, ... Circulation 136 (24), E456-E457, 2017 | 7 | 2017 |
| Projecting effectiveness after ending a randomized controlled trial: a two-state Markov microsimulation model F Yuan, SI Bangdiwala, W Tong, A Lamy International Journal of Technology Assessment in Health Care 36 (4), 317-324, 2020 | 5 | 2020 |
| Cost implications of left atrial appendage occlusion during cardiac surgery: a cost analysis of the LAAOS III trial A Eqbal, W Tong, A Lamy, E Belley‐Cote, D Paparella, ... Journal of the American Heart Association 12 (10), e028716, 2023 | 3 | 2023 |
| The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices F Yuan, SI Bangdiwala, W Tong, A Lamy Expert Review of Pharmacoeconomics & Outcomes Research 23 (1), 69-78, 2023 | 3 | 2023 |
| The cost implications of dabigatran in patients with myocardial injury after non-cardiac surgery A Lamy, W Tong, R Mian, J Vincent, W Szczeklik, BM Biccard, E Duceppe, ... American Journal of Cardiovascular Drugs 22, 83-91, 2022 | 3 | 2022 |
| The cost-effectiveness of rivaroxaban plus aspirin compared with aspirin alone in the COMPASS trial: a US perspective A Lamy, J Eikelboom, W Tong, F Yuan, SI Bangdiwala, J Bosch, ... American Journal of Cardiovascular Drugs 24 (1), 117-127, 2024 | 1 | 2024 |
| Is the Ross procedure a cost-effective alternative compared to mechanical aortic valve replacement in non-elderly patients with aortic stenosis? S Hussain, W Tong, R Whitlock, E Belley-Côté, G McClure, S Sibilio, ... Canadian Journal of Cardiology 35 (10), S167, 2019 | 1 | 2019 |
| Steroids in cardiac surgery (SIRS): economics substudy G McClure, E Belley-Cote, W Tong, F Xie, J Vincent, A Lamy, R Whitlock Canadian Journal of Cardiology 33 (10), S93-S94, 2017 | 1 | 2017 |
